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Abstract
Background: Isolated gestational proteinuria may be part of the pre-eclampsia disease spectrum. Confirmation of its
association with established pre-eclampsia risk factors and higher blood pressure in uncomplicated pregnancies would
support this concept.
Methods: Data from 11,651 women from the Avon Longitudinal Study of Parents and Children who had a term live birth but
did not have pre-existing hypertension or diabetes or develop gestational diabetes or preeclampsia were used. Proteinuria
was assessed repeatedly (median 12 measurements per woman) by dipstick and latent class analysis was used to identify
subgroups of the population with different patterns of proteinuria in pregnancy.
Results: Higher maternal pre-pregnancy body mass index (BMI), younger age, nulliparity and twin pregnancy were
independently associated with increased odds of any proteinuria in pregnancy. Women who experienced proteinuria
showed five patterns: proteinuria in early pregnancy only (#20 weeks gestation), and onset at 21–28 weeks, 29–32 weeks,
33–36 weeks and $37 weeks gestation. There were higher odds of proteinuria onset after 33 weeks in obese women and
after 37 weeks in nulliparous women compared with normal weight and multiparous women respectively. Smoking in
pregnancy was weakly negatively associated with odds of proteinuria onset after 37 weeks. Twin pregnancies had higher
odds of proteinuria onset from 29 weeks. In women with proteinuria onset after 33 weeks blood pressure was higher in
early pregnancy and at the end of pregnancy.
Conclusions: Established pre-eclampsia risk factors were related to proteinuria occurrence in late gestation in healthy term
pregnancies, supporting the hypothesis that isolated gestational proteinuria may represent an early manifestation of pre-
eclampsia.
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Introduction
Pre-eclampsia is a systemic syndrome affecting cardiovascular,
renal and hepatic systems and is associated with increased
maternal and perinatal morbidity and mortality [1–4]. Proteinuria
is the main finding used to distinguish pre-eclampsia from the
lower risk conditions of gestational and chronic hypertension in
pregnancy, although other symptoms may also indicate the
presence of the disease in the absence of proteinuria. The current
International Society for the Study of Hypertension in Pregnancy
(ISSHP) research definition of pre-eclampsia is systolic blood
pressure $140mmHg or diastolic blood pressure $90mmHg with
proteinuria of at least 1+ on urine dipstick occurring on 2
occasions after 20 weeks gestation, whereas that for gestational
hypertension is the same criteria for high blood pressure but
without co-occurrence of proteinuria [5].
Whether isolated gestational proteinuria (i.e. without concom-
itant high blood pressure) is part of the pre-eclampsia disease
continuum is unclear. The classic biological markers of pre-
eclampsia; soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble
endoglin show intermediate increases (between normal and pre-
eclampsia) in women with isolated gestational proteinuria [6,7].
The clinical literature assessing disease progression from isolated
proteinuria to pre-eclampsia is limited, however. A case study of
37 women reported progression from isolated gestational protein-
uria to full pre-eclampsia in 19 (51%) women [8] and in two
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retrospective clinical cohort studies of women with eclampsia, 9.8
and 7.5% respectively had proteinuria alone in the week prior to
the first convulsion [9,10].
If isolated gestational proteinuria is indeed a form of mild pre-
eclampsia or an early manifestation of it that occurs before blood
pressure risk in some women, we would anticipate that established
pre-eclampsia risk factors; maternal pre-pregnancy body mass
index (BMI), age, nulliparity and multiple pregnancy would all be
positively associated with the occurrence of isolated proteinuria
[11], and conversely smoking would be protective [12,13].
Secondly, if disease progression was likely, we would hypothesise
that women who experienced isolated gestational proteinuria
would have higher blood pressure at the end of pregnancy than
women without proteinuria. Lastly, we would anticipate blood
pressure in very early pregnancy also to be higher in these women,
in keeping with an established enhanced vascular risk that is
uncovered by the physiological stress of pregnancy [14]. In the
current study we have tested these three hypotheses in a large
prospective cohort study which routinely recorded antenatal
dipstick proteinuria assessment.
Methods
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective birth cohort study investigating
influences on the health and development of children. The study
has been described in full elsewhere19 and on the website www.
bristol.ac.uk/alspac. Women with expected delivery dates between
1st April 1991 and 31st December 1992 living in Avon during their
pregnancy were eligible for recruitment. Information about the
women and their pregnancies was obtained by questionnaire and
linkage to obstetric medical records. Ethical approval for the study
was obtained from the ALSPAC Law and Ethics Committee and
from the National Health Service (NHS) Local Ethics Committee.
Written consent was obtained from all participants. In total,
14,541 women were enrolled, 13,863 had singleton or twin
pregnancies resulting in all live births and 13,644 of these women
had data abstracted from obstetric records. We excluded mothers
with triplets (N= 3) and quads (N= 1) due to the small numbers
and potential that their identity would be known. We further
excluded 446 (3.3%) women who had a previous diagnosis of
hypertension, 297 (2.2%) women who developed pre-eclampsia in
the index pregnancy (derived from repeat measurements of blood
pressure and proteinuria throughout pregnancy using the ISSHP
definition [5]), 45 (0.3%) women with existing diabetes and 53
(0.4%) women with gestational diabetes; pregnancies unaffected by
these conditions will be referred to as normal for the purposes of
the manuscript. We restricted analyses to term pregnancies ($37
weeks gestation), leaving 11,651 women with at least one
proteinuria measurement who are included in this study.
All urine dipstick measurements for proteinuria and blood
pressure measurements taken routinely as part of antenatal care by
midwives, obstetricians or other relevant health professionals, such
as general practitioners, were abstracted from obstetric medical
records by six trained research midwives. There was no between-
midwife variation in mean values of the data abstracted and error
rates were consistently ,1% in repeated data entry checks.
Proteinuria was recorded as either nil, trace, 1+ (30mg/dl), 2+
(100mg/dl) or 3+ or more (.300mg/dl) and there was a median of
12 and interquartile range of 10 to 14 measurements per woman.
The gestational age at each visit was derived from the date of
measurement and the expected delivery date.
Maternal age at delivery, number of foetuses and offspring sex
were abstracted from obstetric records. Questionnaires adminis-
tered to the women during early pregnancy asked about pre-
pregnancy weight and height, parity, highest educational qualifi-
cation and smoking status. Pre-pregnancy BMI was derived as
weight(kg)/height(m)2 and categorised according to WHO defini-
tions of underweight (,18.5kg/m2), normal (18.5–24.9kg/m2),
overweight (25.0–29.9kg/m2) and obese ($30.0kg/m2). Smoking
was classed as ‘‘never’’ for women who did not smoke immediately
prior to or during pregnancy; ‘‘pre-pregnancy/1st trimester only’’
for women who smoked immediately prior to pregnancy or in the
first 3 months only and ‘‘throughout’’ for women who continued
to smoke after the 1st trimester.
Statistical Analysis
Multiple logistic regression models were used to assess
associations of the risk factors of pre-pregnancy BMI, age, parity,
smoking, education and number of foetuses with odds of having
proteinuria of 1+ or more (compared with nil or trace) at any time
during pregnancy. For this analysis we imputed missing covariate
data using multivariate multiple imputation. Chained equations
were used to produce 20 full datasets and model coefficients were
averaged over the datasets, using Rubin’s rules [15] to produce
standard errors. The outcome, covariates and predictors of
missingness were included in prediction models to impute data.
Latent class analysis was used to extract subgroups of women, or
classes, with similar patterns of proteinuria occurrence during
pregnancy. This analysis is described in File S1 on the journal
website. A latent class model was derived for the whole cohort of
women (N= 11,651), using 6 binary variables to define the
woman’s maximum degree of proteinuria in each of 6 periods of
gestation: #20 weeks, 21–24 weeks, 25–28 weeks, 29–32 weeks,
33–36 weeks and $37 weeks, with categories of ‘‘nil/trace’’ and
‘‘1+ or more’’ or recorded as missing if the woman had no
proteinuria measurements in that period. The best-fitting model
had two latent classes. Further latent class analysis of women who
ever had proteinuria of 1+ or more in pregnancy (N= 1,122), with
maximum degree of proteinuria in each period of pregnancy
defined in three categories as ‘‘nil/trace’’, ‘‘1+’’ or ‘‘2+ or more’’,
resulted in a model with five latent classes.
To assess the associations of the maternal characteristics with
class membership, pseudo-class draws [16] (random sampling from
the distributions of class membership probabilities) were used to
create 200 datasets. Regression coefficients were averaged over
these datasets, with standard errors produced using Rubin’s rules
[15] to incorporate the uncertainty in each woman’s class
membership. Multivariable multinomial regression was used to
assess associations of the characteristics with odds of belonging to
each of Classes 1–5 obtained from latent class analysis of women
who had any proteinuria in pregnancy compared with the pre-
defined subgroup who never had proteinuria.
Since the five classes for women who ever had proteinuria
appeared to represent timing of onset, we also defined subgroups
by the first occurrence of proteinuria of 1+ or more as ‘‘never’’,
‘‘#20 weeks’’, ‘‘21–28 weeks, ‘‘29–32 weeks’’, ‘‘33–36 weeks’’ and
‘‘37+ weeks’’, and used multinomial regression to investigate
associations of the risk factors with membership of these
subgroups, imputing missing covariate data using multivariate
multiple imputation as described above.
To obtain blood pressure at 8 weeks we used the predicted
values of linear spline random effects models for changes in systolic
and diastolic blood pressure with gestational age, with three knots
(indicating changes in slope) at 18, 30 and 36 weeks and baseline
set at 8 weeks [17]. Further description of these models is given in
File S2 on the journal website. Blood pressure at the end of
pregnancy was obtained from the last blood pressure measure-
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ment, or treated as missing for women with no blood pressure
measurements on or after 37 weeks gestation. The difference
between the last blood pressure measurement and predicted blood
pressure at 8 weeks was used to calculate absolute blood pressure
change across pregnancy. We used pseudo-class draws (as above)
and linear regression models to investigate mean differences in
blood pressure at 8 weeks and at the end of pregnancy and
absolute change in blood pressure between each of the latent
classes of women who ever had proteinuria in pregnancy
compared with the subgroup of women who never had
proteinuria. In Model 1 we did not adjust for any other variables,
and in Model 2 we adjusted for each of the maternal
characteristics (pre-pregnancy BMI, age, parity, smoking, educa-
tion and pregnancy type).
Table 1. Characteristics of all women with proteinuria measurements and the subsets with complete data on all of the maternal
covariables and blood pressure.
Maternal Characteristic Full dataset Complete maternal covariable data
Complete maternal covariable and
BP data
(Total N=11,651) (N=8,915) (N=8,568)
(%)/mean (SD) (%)/mean (SD) (%)/mean (SD)
Age (%) N=11651
15–19 4.8 3.4 3.3
20–24 19.3 16.4 16.4
25–29 38.7 39.8 39.8
30–34 27.6 29.9 30.0
35+ 9.6 10.4 10.5
Pre-pregnancy BMI (%) N=9702
Underweight 5.1 4.9 4.7
Normal 74.8 75.2 75.2
Overweight 14.9 14.8 15.0
Obese 5.2 5.1 5.1
Parity (%) N=10824
Nulliparous 44.6 44.7 44.7
Multiparous 55.4 55.3 55.3
Smoking in pregnancy (%) N=10940
Never 66.2 69.0 69.0
Pre-pregnancy/1st trimester 13.9 13.2 13.4
Throughout 20.0 17.8 17.6
Highest qualification (%) N=10489
CSE/Vocational 29.9 27.5 27.4
O Level 34.5 35.1 35.2
A Level 22.5 23.5 23.7
Degree 13.1 13.9 13.8
Pregnancy type (%) N=11651
Male singleton 50.7 50.4 50.4
Female singleton 48.5 48.8 48.8
Twin 0.8 0.8 0.8
BP at 8 weeks (mmHg) N=11644 N=8910
SBP 112.20 (6.48) 112.20 (6.40) 112.21 (6.44)
DBP 66.03 (4.33) 66.02 (4.27) 66.02 (4.29)
BP at end of pregnancy (mmHg) N=11152 N=8569
SBP 119.46 (13.18) 119.39 (13.18) 119.38 (13.18)
DBP 73.80 (10.54) 73.75 (10.49) 73.75 (10.49)
Absolute change in BP (mmHg) N=11150 N=8568
SBP 7.25 (11.78) 7.18 (11.83) 7.18 (11.83)
DBP 7.76 (9.50) 7.73 (9.50) 7.73 (9.50)
Abbreviations: BP blood pressure; DBP diastolic blood pressure; SBP systolic blood pressure; SD standard deviation.
SBP and DBP at 8 weeks are the predicted values of linear spline random effects models for blood pressure change across pregnancy [17]; SBP and DBP at the end of
pregnancy were obtained from the last recorded blood pressure measurement; change across pregnancy is the difference between these two measures.
doi:10.1371/journal.pone.0022115.t001
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We also performed three sensitivity analyses, the first including
the 205 women who had pre-eclampsia (defined according to
ISSHP criteria) but who were delivered at term in our main
analysis dataset, the second restricting to nulliparous women
(N= 4827) and the third excluding 455 women who reported a
previous diagnosis of kidney disease in a questionnaire adminis-
tered during pregnancy. Latent class models were fitted in Mplus
version 5 and all other analyses were completed using Stata
version 11.1.
Results
The characteristics of all women included in the latent class
analysis (N= 11,651), the subset with complete data on all
maternal characteristics (N=8,915) and the subset with complete
data on all maternal characteristics and blood pressure variables
(N= 8,568) are shown in Table 1. Distributions of characteristics
in both of the subsets were similar to those in the full dataset.
Single episodes of isolated gestational proteinuria were relatively
common with 894 women (7.7%) experiencing proteinuria of 1+
or more on one occasion only, 157 (1.3%) on 2 occasions and 71
(0.6%) on more than 2 occasions. With respect to severity of
proteinuria 972 women (8.3%) had an occurrence of 1+
proteinuria, 176 (1.5%) experienced 2+ and 38 (0.3%) experienced
3+ or more. Compared to reference categories the odds of
experiencing proteinuria were higher if the woman was overweight
or obese, aged ,20 or 20–24 years, nulliparous or pregnant with
twins (Table 2).
Latent class analysis of the full cohort produced two classes of
women (Table 3). The first class (N= 11,511, 98.8%) had a low
probability of proteinuria throughout gestation (Figure 1). The
second class (N= 140, 1.2%) had a higher probability of
proteinuria, which was greatest in late pregnancy (Figure 1).
Restriction of the analyses to only those women who experienced
proteinuria during pregnancy, N= 1,122, produced five latent
classes related to gestational age (i.e. timing of occurrence in
pregnancy) (Table 3). The probability of experiencing proteinuria
in each of these gestational periods is shown in Figure 2, with clear
differential patterns regarding the timing of onset of proteinuria
identified by the latent class analysis.
The associations between the maternal characteristics and
belonging to each of the five classes are shown in Table 4, with the
probabilities of belonging to each class by maternal characteristic
shown in Table S3. Compared with those in the reference
Table 2. Odds ratios for ever having proteinuria of 1+ or
more at any time during pregnancy in mutually-adjusted
model (N = 11,651)a.
Maternal characteristic Odds ratio 95% confidence interval
Pre-pregnancy BMI (kg/m2)
Underweight 0.88 (0.63, 1.22)
Normal 1 -
Overweight 1.30 (1.09, 1.55)
Obese 1.75 (1.34, 2.28)
Age (yrs)
,20 1.49 (1.13, 1.97)
20–24 1.33 (1.13, 1.58)
25–29 1 -
30–34 1.00 (0.84, 1.17)
35+ 0.96 (0.75, 1.22)
Parity
Nulliparous 1 -
Multiparous 0.87 (0.76, 1.00)
Smoking during pregnancy
Never 1 -
Pre-pregnancy/1st trimester 1.01 (0.83, 1.23)
Throughout 1.09 (0.93, 1.28)
Highest qualification
CSE/vocational 1.09 (0.92, 1.28)
O level 1 -
A level 1.03 (0.86, 1.24)
Degree 0.83 (0.65, 1.06)
Pregnancy type
Male singleton 1 -
Female singleton 1.08 (0.96, 1.23)
Twin 3.09 (1.88, 5.08)
aMissing covariate data was imputed using multivariate multiple imputation.
doi:10.1371/journal.pone.0022115.t002
Table 3. Description of the latent classes in analysis of the whole cohort and of the subset who ever had proteinuria assigning
women to their most likely class.
Latent Class N (%)
N with complete data on all
covariates (%) Description
Whole cohort analysis:
Class 1 11511 (98.8) 8831 (99.1) Low probability of proteinuria
Class 2 140 (1.2) 84 (0.9) High probability of proteinuria
Analysis of women who ever had proteinuria:
Class 1 101 (9.0) 77 (9.7) Proteinuria only in early pregnancy
Class 2 104 (9.3) 71 (8.9) Onset of proteinuria 21–28 weeks
Class 3 137 (12.2) 95 (11.9) Onset of proteinuria 29–32 weeks
Class 4 276 (24.6) 173 (21.7) Onset of proteinuria 33–36 weeks
Class 5 504 (44.9) 380 (47.7) Onset of proteinuria 37 weeks
gestation or later
doi:10.1371/journal.pone.0022115.t003
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categories, women aged ,20 or 20–24 years and nulliparous
women were more likely to belong to Class 1 (proteinuria #20
weeks). There were no strong associations of the risk factors with
membership of Class 2 (proteinuria onset 21–28 weeks). Women
with twin pregnancies and women who smoked pre-pregnancy/1st
trimester were more likely to belong to Class 3 (proteinuria onset
29–32 weeks). Obese women and those with twins were more
likely to belong to Class 4 (proteinuria onset between 33 and 36
weeks). Notably there was an increasing trend in odds of belonging
to Class 5 (proteinuria onset 37 weeks or later) with higher BMI
category and nulliparous women were also more likely to belong to
this class. There was also some evidence that women who smoked
pre-pregnancy/1st trimester or throughout pregnancy were less
likely to belong to Class 5 than those who never smoked. When we
defined the subgroups by the onset of proteinuria measurement
and analysed by multinomial regression analysis, the results were
similar, further supporting the interpretation of these classes as
representing the timing of onset of proteinuria (Table S4).
Assessment of the association of these proteinuric classes with
blood pressure at the beginning and end of pregnancy is shown in
Table 5 and Figure 3. Of the five different classes it was striking
that women in Class 5 (proteinuria onset 37 weeks or later) had
higher SBP and DBP at 8 weeks and also at the end of pregnancy
and overall experienced a greater absolute rise in SBP and DBP
across pregnancy compared with women with no proteinuria in
fully adjusted models (Table 5).
In the sensitivity analysis in which we included women who had
pre-eclampsia during the pregnancy, but delivered at term
(N= 205 women added), and all other elements of our eligible
cohort remained, results were largely the same as those already
presented when these women were not included. The main
exception was that in the latent class analyses of women who ever
Figure 2. Probability of proteinuria in each category of gestational age in the latent class model for women who experienced 1+ or
more episodes of proteinuria in pregnancy (N=1,122).
doi:10.1371/journal.pone.0022115.g002
Figure 1. Probability of proteinuria of 1+ or more by gestational age in the latent class model for all women (N=11,651).
doi:10.1371/journal.pone.0022115.g001
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had proteinuria an additional sixth class (to the five produced in
the main analyses) which included a heterogeneous group of
women with proteinuria onset 21–24 weeks, those with proteinuria
throughout pregnancy and those with repeated proteinuria of 2+
or more (representing 3.6% of women with at least one episode of
proteinuria) was produced. Also instead of the class with
proteinuria onset 21–28 weeks there was a class with proteinuria
onset 25–28 weeks (6.3%). Associations of the maternal risk factors
with membership of classes were comparable with the main
analysis, though the reduced odds of proteinuria in later
pregnancy in women who smoked in early or throughout
pregnancy was strong in this sensitivity analysis including women
with pre-eclampsia. In terms of characteristics associated with the
new/different classes, maternal age ,20 years was associated with
greater odds of belonging to the additional sixth class and women
with twin pregnancies were more likely to belong to the class with
proteinuria onset 25–28 weeks compared with singleton pregnan-
cies. Repeating the analysis with restriction to nulliparous women
Table 4. Odds ratios for class membership (analysis of women who ever had proteinuria) compared with women who never had
proteinuria in multivariable multinomial regression model (N = 8,915).
Maternal Characteristic Class 1
a (0.84%) Class 2a (0.87%) Class 3a (1.08%) Class 4a (1.91%) Class 5a (4.23%)
‘‘Onset #20 weeks’’ ‘‘Onset 21–28 weeks’’ ‘‘Onset 29–32 weeks’’ ‘‘Onset 33–36 weeks’’ ‘‘Onset 37+ weeks’’
Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI
Pre-pregnancy BMI (kg/
m2)
Underweight 1.11 (0.41, 3.01) 0.33 (0.05, 2.32) 0.35 (0.07, 1.67) 1.53 (0.82, 2.85) 0.50 (0.25, 0.98)
Normal 1 - 1 - 1 - 1 - 1 -
Overweight 1.10 (0.56, 2.14) 1.31 (0.71, 2.44) 0.84 (0.46, 1.57) 1.29 (0.85, 1.97) 1.30 (0.99, 1.72)
Obese 1.60 (0.65, 3.97) 1.68 (0.71, 3.99) 1.50 (0.68, 3.31) 2.28 (1.34, 3.88) 1.90 (1.27, 2.82)
P for all classes= 0.006
Age (yrs)
,20 6.53 (2.58, 16.55) 2.26 (0.79, 6.46) 1.28 (0.41, 4.00) 0.80 (0.29, 2.20) 1.20 (0.68, 2.13)
20–24 2.46 (1.30, 4.66) 1.42 (0.73, 2.75) 1.20 (0.67, 2.14) 1.25 (0.81, 1.93) 1.12 (0.82, 1.52)
25–29 1 - 1 - 1 - 1 - 1 -
30–34 0.79 (0.41, 1.53) 1.11 (0.60, 2.04) 0.91 (0.54, 1.53) 1.09 (0.74, 1.60) 1.06 (0.82, 1.38)
35+ 0.75 (0.29, 1.94) 0.59 (0.20, 1.76) 0.58 (0.24, 1.40) 0.96 (0.54, 1.72) 1.24 (0.86, 1.78)
P for all classes= 0.044
Parity
Nulliparous 1 - 1 - 1 - 1 - 1 -
Multiparous 1.68 (1.00, 2.84) 1.16 (0.69, 1.96) 1.53 (0.97, 2.41) 1.10 (0.79, 1.53) 0.62 (0.49, 0.77)
P for all classes ,0.001
Smoking during
pregnancy
Never 1 - 1 - 1 - 1 - 1 -
Pre-pregnancy/1st trimester 0.44 (0.17, 1.12) 1.33 (0.67, 2.63) 1.79 (1.04, 3.07) 1.31 (0.85, 2.01) 0.74 (0.53, 1.03)
Throughout 0.73 (0.38, 1.38) 1.46 (0.80, 2.64) 1.22 (0.71, 2.12) 0.96 (0.63, 1.47) 0.77 (0.57, 1.04)
P for all classes= 0.084
Highest qualification
CSE/vocational 0.96 (0.53, 1.76) 1.20 (0.69, 2.10) 1.56 (0.92, 2.63) 1.39 (0.95, 2.03) 1.08 (0.82, 1.41)
O level 1 - 1 - 1 - 1 - 1 -
A level 1.38 (0.73, 2.62) 0.63 (0.28, 1.42) 1.63 (0.93, 2.88) 1.16 (0.76, 1.78) 1.05 (0.80, 1.39)
Degree 1.14 (0.48, 2.71) 1.13 (0.50, 2.59) 0.89 (0.37, 2.13) 0.70 (0.38, 1.32) 0.76 (0.52, 1.10)
P for all classes= 0.281
Pregnancy type
Male singleton 1 - 1 - 1 - 1 - 1 -
Female singleton 1.02 (0.63, 1.63) 1.00 (0.61, 1.62) 1.05 (0.69, 1.60) 1.35 (0.98, 1.86) 0.97 (0.79, 1.20)
Twin -b -b 4.64 (0.91, 23.64) 5.24 (1.53, 17.93) 8.64 (3.77, 19.81) 1.39 (0.43, 4.50)
P for all classes ,0.001
Abbreviations: CI confidence interval; BMI body mass index.
aVersus never had proteinuria (N = 8,119, 91.07%).
bOdds ratio could not be estimated as there were too few women with this characteristic in this class.
doi:10.1371/journal.pone.0022115.t004
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(N= 5,997 multiparous women excluded) or excluding women
with a previous diagnosis of kidney disease (N= 455) produced
results consistent with the main analysis.
Discussion
In a large cohort of women we demonstrate that established risk
factors for pre-eclampsia are associated with isolated gestational
proteinuria. Furthermore, using a novel latent class method, we
establish that these risk factors are related to different patterns of the
onset of proteinuria, with this occurring earlier in twin pregnancy
than in relation to obesity or nulliparity. Lastly, women who develop
proteinuria in late gestation commence pregnancy with higher
systolic and diastolic blood pressure and this relative increase is
maintained across gestation. Our ability to exclude women with pre-
existing hypertension or diabetes or those who subsequently develop
gestational diabetes or pre-eclampsia, further enhances their validity
as our associations are not driven by such women. Collectively, our
results support the hypotheses that isolated gestational proteinuria is
part of the disease spectrum of pre-eclampsia, that disease progression
is biologically plausible and that women enter pregnancy with an
established risk profile which is determined genetically or through
lifestyle but subsequently manifests clinically as pregnancy complica-
tions including that of isolated gestational proteinuria.
Of the studied maternal risk factors young maternal age, higher
pre-pregnancy BMI, nulliparity and twin pregnancy were all
associated with increased odds of experiencing proteinuria. Using
latent class analysis we identified that the individual maternal risk
factors were associated with different patterns of proteinuria onset.
Specifically younger women were more likely to experience
proteinuria in early pregnancy, but not later in pregnancy,
agreeing with evidence that younger maternal age is not related to
pre-eclampsia risk when adjusting for parity [18]. Maternal obesity
was associated with proteinuria onset from 33 weeks onwards,
nulliparity from 37 weeks and twin pregnancy from 29 weeks.
These patterns of onset coincide with our previously reported
temporal analysis of the rise in blood pressure across gestation
[17]. In our previous study of blood pressure change during
pregnancy conducted in this cohort we found that in obese women
blood pressure began to rise at 30 weeks gestation as compared to
18 weeks for normal weight women, and also rose more rapidly
[17]. In nulliparous women, although blood pressure was higher
than for multiparous women throughout pregnancy, there were
faster gains in diastolic blood pressure from 30 weeks and systolic
blood pressure from 36 weeks onwards. In twin pregnancies again
the rise in blood pressure began at around 30 weeks and was more
rapid than singleton pregnancies [17]. Thus, our two studies
together suggest that established risk factors for pre-eclampsia are
Table 5. Mean differences (95% confidence interval) in blood pressure at the beginning and end of pregnancy and absolute
change in blood pressure for each of the classes of women who ever had proteinuria compared with those who did not (N= 8,568).
Class SBP at 8 weeks
SBP at end of
pregnancy
SBP change
across
pregnancy DBP at 8 weeks
DBP at end of
pregnancy
DBP change across
pregnancy
(comparison group is women
who never had proteinuria;
91.07%)
Mean difference
(95% CI)
Mean difference
(95% CI)
Mean difference
(95% CI)
Mean difference
(95% CI)
Mean difference
(95% CI)
Mean difference
(95% CI)
Class 1 (0.84%)
‘‘Onset #20 weeks’’
Model 1 1.76 (0.17, 3.34) 20.05 (23.28, 3.19) 21.80 (24.74, 1.14) 0.91 (20.15, 1.97) 20.56 (23.14, 2.02) 21.47 (23.80, 0.87)
Model 2 1.74 (0.24, 3.25) 0.14 (23.04, 3.32) 21.60 (24.53, 1.33) 1.01 (0.02, 2.01) 20.30 (22.83, 2.22) 21.32 (23.63, 1.00)
Class 2 (0.87%)
‘‘Onset 21–28 weeks’’
Model 1 20.46 (22.01, 1.09) 0.73 (22.45, 3.91) 1.19 (21.67, 4.05) 0.16 (20.87, 1.19) 0.86 (21.67, 3.38) 0.69 (21.59, 2.98)
Model 2 20.83 (22.31, 0.66) 0.31 (22.82, 3.44) 1.14 (21.71, 3.99) 0.05 (20.91, 1.02) 0.68 (21.78, 3.14) 0.63 (21.63, 2.89)
Class 3 (1.08%)
‘‘Onset 29–32 weeks’’
Model 1 20.72 (22.09, 0.64) 20.17 (22.98, 2.64) 0.55 (21.98, 3.09) 20.43 (21.35, 0.49) 0.59 (21.63, 2.82) 1.03 (20.98, 3.03)
Model 2 20.74 (22.04, 0.56) 20.11 (22.87, 2.65) 0.63 (21.90, 3.16) 20.33 (21.19, 0.54) 0.80 (21.37, 2.98) 1.13 (20.86, 3.11)
Class 4 (1.91%)
‘‘Onset 33–36 weeks’’
Model 1 1.29 (0.28, 2.30) 2.84 (0.77, 4.91) 1.55 (20.30, 3.41) 0.73 (0.06, 1.40) 2.44 (0.80, 4.08) 1.71 (0.23, 3.19)
Model 2 0.95 (20.01, 1.92) 2.42 (0.39, 4.46) 1.47 (20.39, 3.33) 0.54 (20.10,1.17) 2.16 (0.56, 3.76) 1.62 (0.15, 3.09)
Class 5 (4.23%)
‘‘Onset 37+ weeks’’
Model 1 2.06 (1.39, 2.73) 8.66 (7.29, 10.03) 6.60 (5.37, 7.84) 1.73 (1.29, 2.18) 8.62 (7.54, 9.70) 6.89 (5.91, 7.87)
Model 2 1.52 (0.88, 2.16) 7.86 (6.52, 9.21) 6.34 (5.11, 7.58) 1.36 (0.94, 1.78) 7.92 (6.86, 8.98) 6.56 (5.59, 7.54)
Abbreviations: SBP systolic blood pressure; DBP diastolic blood pressure; CI confidence interval.
SBP and DBP at 8 weeks are the predicted values of linear spline random effects models for blood pressure change across pregnancy [17]; SBP and DBP at the end of
pregnancy were obtained from the last recorded blood pressure measurement; change across pregnancy is the difference between these two measures.
Model 1 is unadjusted; Model 2 is adjusted for maternal pre-pregnancy BMI, age, parity, smoking, education and pregnancy type.
doi:10.1371/journal.pone.0022115.t005
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associated with blood pressure change and isolated gestational
proteinuria in normal term pregnancies.
The striking similarity between the timing of the observed
increases in blood pressure (in our previous study) and the timing
of onset of proteinuria (in our current study) which is apparent in
obese women, nulliparous women and women pregnant with twins
may reflect two potential non-mutually exclusive mechanisms.
Firstly, that the release of factors from the placenta influences both
blood pressure increases and glomerular endothelial dysfunction;
and/or, secondly, that the rise in blood pressure causes previously
negligible proteinuria to progress to clinically significant levels.
Indeed in pre-eclampsia, proteinuria is thought to stem from the
placental production of high levels of sFlt-1, leading to inactivation
of free vascular endothelial growth factor (VEGF) on podocytes
and glomerular endotheliosis [19]. Furthermore proteinuria may
be made more severe by high blood pressure, due to increased
pressure on the glomerular endothelium [19].
In agreement with our findings, BMI has also been previously
associated with an increased risk of proteinuria in pregnancy
[20,21] and uncomplicated twin pregnancies exhibit both higher
protein:creatinine ratios at 34–38 weeks and absolute change
across gestations compared with singleton pregnancies [22]. Our
observed lack of relationship between twin pregnancies and onset
of proteinuria after 37 weeks, is potentially attributable to 75% of
the twin pregnancies being delivered at 37 or 38 weeks.
Smoking is known to be protective against pre-eclampsia and in
accordance with this smoking either pre-pregnancy/first trimester
only or throughout pregnancy were both weakly associated with
Figure 3. Mean and 95% confidence intervals of early and late pregnancy blood pressure by classes of women who ever had
proteinuria and the subgroup without proteinuria. SBP and DBP at 8 weeks are the predicted values from linear spline random effects models
for blood pressure change across pregnancy [17]; SBP and DBP at the end of pregnancy were obtained from the last recorded blood pressure
measurement provided that this occurred at $37 weeks. The 8,568 women with complete data on all maternal characteristics and blood pressure
measures were included.
doi:10.1371/journal.pone.0022115.g003
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reduced odds of proteinuria onset after 37 weeks. This effect was
somewhat stronger when women with pre-eclampsia were
included in analyses. Our previous findings showed that women
who smoked throughout pregnancy had consistently lower blood
pressure in pregnancy, while those who smoked only in the first
trimester had similar patterns of blood pressure change in late
pregnancy to those who never smoked [17]. Thus, it is plausible
that the reduction in risk of proteinuria onset in late pregnancy in
smokers occurs via a different mechanism to the decreased blood
pressure.
In keeping with an increased risk of disease progression to pre-
eclampsia [8], we found that blood pressure was higher at the end of
pregnancy in women who had onset of proteinuria after 33 weeks
gestation. Furthermore in these same classes of women blood pressure
was higher in early pregnancy. This suggests that any increased risk of
hypertensive disorders of pregnancy in these women, partly reflects
genetic predisposition or pre-pregnancy lifestyle rather than being
solely attributable to pregnancy related factors. Consistent with this,
outside of pregnancy, obesity, blood pressure and older age are all
positively associated with proteinuria [23–25].
Less than 10% of women experienced proteinuria during
pregnancy, and only 2% on more than one occasion, so we could
not model longitudinal changes in proteinuria. Aggregating
proteinuria measurements over periods of gestational age enabled
us to use latent class analysis to define subgroups of women by
patterns in the timing and severity of proteinuria and relate these
subgroups to pre-eclampsia risk factors. All models had entropy
values $0.89, indicating that women had high probabilities of
belonging to their most likely class and the classes represented
distinct clusters of patterns. Furthermore, we were able to still
include women who did not have proteinuria measurements in all
periods of gestation by assigning them a probability of class
membership reflecting the uncertainty due to the missing data.
There is increasing awareness of the benefits of latent class analysis
for repeat measurements, with recent characterisation of patterns
of clinical symptoms such as wheeze [26] and back pain [27]
reported in repeated questionnaires. We have extended the utility
of this technique to demonstrate that it can also be valuable in
analysis of repeated routine clinical measurements on a categorical
scale, measured at different time points for each individual,
particularly where some values are uncommon.
Our study has a number of strengths including its large size,
detailed repeat measurements and our novel application of latent
class analysis, to overcome the methodological challenges that arise
due to proteinuria being a sparse discrete categorical variable. In
addition to these significant strengths we do, however, acknowledge
that our study was limited by the use of routine qualitative dipstick
measurements of proteinuria, which are less accurate than 24 hour
collections or protein/creatinine ratio and more influenced by urine
concentration. However, until recently dipstick was the onlymethod
of feasibly assessing proteinuria in routine antenatal practice and is
currently being used to screen for pre-eclampsia in the UK andmost
other countries, and thus our results are applicable to clinical
practice. In clinical practice dipstick measurements indicating pre-
eclampsia should be confirmed by a timed urine collection (e.g.
24 hour urine) or protein/creatinine ratio [5]. We do not have such
measurements available in our study and it would be valuable to
examine whether our findings replicate in studies that do have the
ability to confirm proteinuria and that have quantitative measure-
ments. Since the blood pressure and proteinuria measurements
were routinely collected at antenatal visits the methods of
measurement could not be standardised between the clinics
included in the study. However, this also means that our data are
reflective of a clinical setting, where women are assessed by different
staff in different locations (e.g. home visits, primary care, secondary
care) throughout their pregnancy. Also, we recognise that there are
other aetiologies of isolated gestational proteinuria which are
unrelated to pre-eclampsia and were unable to exclude these from
our data, but in clinical practice other causes should be considered
in order to rule these out. We also assumed that women without any
occurrences of proteinuria on urine dipstick tests would not have
had proteinuria at times in pregnancy when they were not tested,
but this seems plausible given the high number of repeated
measurements per woman.
Conclusions
In this study we demonstrate that isolated gestational protein-
uria is relatively common affecting ,10% of women, and that it
exhibits positive associations with the known maternal pre-
eclampsia risk factors; obesity, nulliparity, multiple pregnancy
and blood pressure. Our observation that isolated gestational
proteinuria and pre-eclampsia share the same maternal anteced-
ents supports the concept that they are part of the same disease
spectrum. However, these findings require confirmation by studies
with quantitative accurate measurements of proteinuria. While our
findings are not sufficient to support the changing of clinical
management of women who experience isolated gestational
proteinuria, they indicate a clear need for future studies which
assess the potential for progression to pre-eclampsia in women
with isolated gestational proteinuria and to evaluate the health
benefit of more intense antenatal monitoring in those women with
isolated gestational proteinuria.
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